Cargando…
Tenecteplase or Alteplase: What Is the Thrombolytic Agent of the Future?
PURPOSE OF REVIEW: Alteplase has been the thrombolytic of choice for acute ischaemic stroke for more than two decades. A thrombolytic which is easier to administer and with improved or comparable safety and efficacy is desirable. Tenecteplase has emerged as a potential successor, and its off-license...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362569/ https://www.ncbi.nlm.nih.gov/pubmed/35965955 http://dx.doi.org/10.1007/s11940-022-00733-4 |